Patent: 5,976,546
✉ Email this page to a colleague
Summary for Patent: 5,976,546
| Title: | Immunostimulatory compositions |
| Abstract: | Disclosed are therapeutic compositions and methods for inducing cytotoxic T cell responses in vitro and in vivo. The therapeutic compositions consist of antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen. Also disclosed are expression vectors and systems for producing the polypeptide complexes. |
| Inventor(s): | Reiner Laus, Curtis Landon Ruegg, Hongyu Wu |
| Assignee: | Dendreon Pharmaceuticals LLC |
| Application Number: | US09/146,283 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,976,546
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Dendreon Pharmaceuticals Llc | PROVENGE | sipuleucel-t | Injection | 125197 | April 29, 2010 | ⤷ Start Trial | 2018-09-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
